These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26978338)

  • 1. Functionalization of a Triazine Dendrimer Presenting Four Maleimides on the Periphery and a DOTA Group at the Core.
    Lee C; Ji K; Simanek EE
    Molecules; 2016 Mar; 21(3):335. PubMed ID: 26978338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.
    Lim J; Venditto VJ; Simanek EE
    Bioorg Med Chem; 2010 Aug; 18(15):5749-53. PubMed ID: 20615715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of Glutathione-Mediated Degradation of Thiol-Maleimide Conjugates.
    Wu H; LeValley PJ; Luo T; Kloxin AM; Kiick KL
    Bioconjug Chem; 2018 Nov; 29(11):3595-3605. PubMed ID: 30285419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazine dendrimers with orthogonally protected amines on the periphery. Masking amines with Dde and BOC groups provides an alternative to carrying protected alcohols and disulfides through an iterative synthesis.
    Umali AP; Crampton HL; Simanek EE
    J Org Chem; 2007 Dec; 72(26):9866-74. PubMed ID: 18052073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
    Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
    J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of triazine based dendrimers for delivery of antitumor agent.
    Bansal KK; Kakde D; Gupta U; Jain NK
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8395-404. PubMed ID: 21121345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules.
    Ahlgren S; Orlova A; Rosik D; Sandström M; Sjöberg A; Baastrup B; Widmark O; Fant G; Feldwisch J; Tolmachev V
    Bioconjug Chem; 2008 Jan; 19(1):235-43. PubMed ID: 18163536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
    Lewis MR; Shively JE
    Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and computational evidence for an inversion in guest capacity in high-generation triazine dendrimer hosts.
    Lim J; Pavan GM; Annunziata O; Simanek EE
    J Am Chem Soc; 2012 Feb; 134(4):1942-5. PubMed ID: 22239724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protected maleimide building blocks for the decoration of peptides, peptoids, and peptide nucleic acids.
    Elduque X; Sánchez A; Sharma K; Pedroso E; Grandas A
    Bioconjug Chem; 2013 May; 24(5):832-9. PubMed ID: 23582188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of odd generation triazine dendrimers using a divergent, macromonomer approach.
    Lim J; Mintzer MA; Perez LM; Simanek EE
    Org Lett; 2010 Mar; 12(6):1148-51. PubMed ID: 20170155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological assessment of a triazine dendrimer with approximately 16 Paclitaxel groups and 8 PEG groups.
    Lee C; Lo ST; Lim J; da Costa VC; Ramezani S; Öz OK; Pavan GM; Annunziata O; Sun X; Simanek EE
    Mol Pharm; 2013 Dec; 10(12):4452-61. PubMed ID: 24134039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting protected maleimides to modify oligonucleotides, peptides and peptide nucleic acids.
    Paris C; Brun O; Pedroso E; Grandas A
    Molecules; 2015 Apr; 20(4):6389-408. PubMed ID: 25867825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
    Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
    J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kilogram-scale synthesis of a second-generation dendrimer based on 1,3,5-triazine using green and industrially compatible methods with a single chromatographic step.
    Chouai A; Simanek EE
    J Org Chem; 2008 Mar; 73(6):2357-66. PubMed ID: 18307354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide dendrimer enzyme models for ester hydrolysis and aldolization prepared by convergent thioether ligation.
    Uhlich NA; Darbre T; Reymond JL
    Org Biomol Chem; 2011 Oct; 9(20):7071-84. PubMed ID: 21879129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and theoretical studies of selective thiol-ene and thiol-yne click reactions involving N-substituted maleimides.
    Stolz RM; Northrop BH
    J Org Chem; 2013 Aug; 78(16):8105-16. PubMed ID: 23924266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile Preparation of PNA-Peptide Conjugates with a Polar Maleimide-Thioether Linkage.
    Hansen AM; Shaikh AY; Franzyk H
    Methods Mol Biol; 2020; 2105():97-118. PubMed ID: 32088866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence sensitivity and pH dependence of maleimide conjugated N-terminal cysteine peptides to thiazine rearrangement.
    Gober IN; Riemen AJ; Villain M
    J Pept Sci; 2021 Jul; 27(7):e3323. PubMed ID: 33786923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.
    Patra S; Kozura B; Huang AY; Enciso AE; Sun X; Hsieh JT; Kao CL; Chen HT; Simanek EE
    Org Lett; 2013 Aug; 15(15):3808-11. PubMed ID: 23869522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.